The Oral Microbiome and Alzheimer's — What the Research Actually Shows
In 2019, a team of researchers published a paper in Science Advances that generated more discussion in the neuroscience community than almost anything else that year. They had been looking at post-mortem brain tissue from people who died with Alzheimer's disease. What they found was that in 96 percent of the samples they examined, there was DNA from a bacterium that lives in the gum pockets of people with periodontal disease. More than that: they found the enzymes this bacterium produces — called gingipains — actively present in the brain tissue, at levels that correlated with the severity of two hallmark Alzheimer's pathologies. This was not a correlation between having gum disease and having Alzheimer's. This was finding the organism itself, inside the brain.
Dominy and colleagues worked with brain tissue from Alzheimer's patients, from healthy controls, and from living Alzheimer's patients who had consented to spinal fluid analysis. They found the bacteria's DNA and its gingipain enzymes in the Alzheimer's brains. In mouse models, infecting animals with the oral bacterium produced features of Alzheimer's pathology: amyloid beta accumulation, tau phosphorylation, and neuronal death in the hippocampus. When they gave mice a drug designed to inhibit gingipain activity, it reduced bacterial load in the brain and attenuated neurodegeneration.
The paper was significant because it moved beyond epidemiological association into mechanism. The gingipain enzymes are protease enzymes — they cut proteins. The research showed they can degrade tau and ApoE, two proteins central to Alzheimer's pathology. They also activate neuroinflammatory pathways.
How bacteria might reach the brain
The most likely routes are vascular and neural. Bacteria from inflamed gingival tissue enter the bloodstream during routine activities. From there, they can potentially cross the blood-brain barrier, particularly if that barrier is already compromised — which it is in aging, in inflammatory states, and in early neurodegeneration. There is also a neural route: some oral bacteria have been found associated with the trigeminal nerve, which connects the jaw directly to the brain stem without crossing the bloodstream at all.
The epidemiological signal
Beydoun and colleagues, in a 2020 study in the Journal of Alzheimer's Disease, followed older adults prospectively and found that the presence of certain periodontal pathogens in serum was associated with incident dementia over the follow-up period. Multiple systematic reviews have found roughly a twofold elevated risk of Alzheimer's disease in people with chronic periodontitis, after adjusting for standard confounders.
The protective side
A 2021 network analysis identified a distinct oral bacterial module — anchored by Neisseria and Haemophilus species — whose abundance correlated with better cognitive performance. These are the same nitrate-reducing bacteria described in blood pressure research: organisms that produce nitrite, which the body converts to nitric oxide, which supports both vascular function and brain perfusion.
What this does and does not mean
No clinical trial has shown that treating gum disease prevents Alzheimer's disease. The presence of oral bacteria in Alzheimer's brains does not prove those bacteria caused the disease — reverse causation is possible. What the research does support is a biologically plausible mechanism, a consistent epidemiological signal, and the presence of the specific organism in brain tissue at levels that correlate with disease markers.
The oral microbiome is not the cause of Alzheimer's. But it may be one of the inputs into a decades-long process — and it is one of the few inputs that can be directly measured and shifted.
Cnvrg surfaces this research for users over 45 with elevated levels of harmful oral bacteria, particularly when combined with other markers of chronic inflammation.
Sources
Dominy SS et al. Sci Adv. 2019. DOI: 10.1126/sciadv.aau3333. Beydoun MA et al. J Alzheimers Dis. 2020. DOI: 10.3233/JAD-200064. Vanhatalo A et al. Redox Biol. 2021. DOI: 10.1016/j.redox.2021.101933. Borrego-Ruiz A et al. AIMS Microbiol. 2025. DOI: 10.3934/microbiol.2025013.